News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioInvent (BOVNF) Interim Report 1 January – 30 June 2013


7/25/2013 9:19:52 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Important events in the second quarter and after the end of the reporting period

· BioInvent received in July a milestone payment when a partner programme entered the clinical phase.
· The agreement with Mitsubishi Tanabe Pharma Corporation for research and development of antibody drugs was extended and expanded.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
BioInvent
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES